An analysis of TCGA database revealed that low IDH1 mRNA expression levels were significantly associated with poor overall survival in patients with breast cancer (CHR, 1.80; 95% CI% 1.10-2.94; p = 0.02) (Additional file 4: Table S4). Here, IDH1 is linked to breast cancer.